HROW
HROW clinical trials: HARROW, INC.
Every trial on ClinicalTrials.gov where HARROW, INC. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 14
- Trials linked
- 7
- As lead sponsor
- 7
- As collaborator
- 1
- Primary completions as lead sponsor, next 90 days
HROW on the catalyst calendar · HROW registry changes
- Primary completion Dec 2026Sponsor estimatePhase 3NCT07832552A Phase 3 Study Evaluating the Safety and Efficacy of TRIESENCE® (Injectable Suspension) for the Treatment of Ocular Inflammation and...Harrow Inc · Postoperative Ocular InflammationEnrolling by invitationHROWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 30, 2021ActualPhase 4NCT07588074Tolerability Comparison of Flarex to Lotemax SMHarrow Inc · Ocular InflammationCompletedHROWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2026Sponsor estimatePhase 4NCT07456826Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus...Harrow Inc · Diabetic Macular Edema (DME)Enrolling by invitationHROWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 15, 2024ActualPhase 4NCT05934253The Effects of Low Viscosity Chloroprocaine Ophthalmic Gel 3% on the Bactericidal Action of Povidone-IodineHarrow Inc · AntisepticCompletedHROWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2014Sponsor estimatePhase 3NCT01890902Efficacy and Safety of Impracor (Ketoprofen 10% Cream) Compared With Placebo in the Treatment of Acute Pain (Flare) Associated With...Imprimis Pharmaceuticals, Inc. · Acute Pain (Flare) Associated With Osteoarthritis (OA) of the KneeWithdrawnHROWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2009ActualPhase 3NCT00765700Ketoprofen 10% Cream for Treatment of Pain Associated With Mild to Moderate Acute Soft Tissue InjuryImprimis Pharmaceuticals, Inc. · SprainCompletedHROWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredPhase 3NCT01223053Ketoprofen 10% Cream for Treatment of Pain Associated With Mild to Moderate Acute Soft Tissue InjuryImprimis Pharmaceuticals, Inc. · SprainWithdrawnHROWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 7, 2026ActualPhase 4NCT07779356Patient Comfort Following Intravitreal Injections Using Iheezo Versus Standard AnesthesiaRetina Consultants of Delmarva · Macular DegenerationCompletedHROWCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 1, 2027Sponsor estimatePhase 4NCT07224529Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland DysfunctionUniversity of Alabama at Birmingham · Meibomian Gland Dysfunction (MGD)RecruitingHROWCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 31, 2027Sponsor estimatePhase 4NCT07368595Comparison of Conjunctival Goblet Cell Density in Dry Eye Patients Treated With Cyclosporine 0.1% Dissolved in Perfluorobutylpentane...Baylor College of Medicine · Dry Eye Disease (DED)Not yet recruitingHROWCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 30, 2026Sponsor estimateNo phase registeredNCT07566975Real-World Assessment of VEVYE® for Short-Term Symptom and Sign Improvement of Dry Eye Disease in a Neuro-Ophthalmology Clinic: A...Neuro-Ophthalmology of Texas · Dry EyeRecruitingHROWCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 4, 2019ActualPhase 4NCT03578276Prophylactic Treatment: Lessdrops™ vs Standard Drops RegimenCarolina Eyecare Physicians, LLC · CataractCompletedHROWCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 16, 2021ActualPhase 4NCT03640650Economic Impact of Dropless Therapy Versus Usual Care for Cataract Surgery: A Real-World Study.PeriPharm · Cataract SurgeryTerminatedHROWCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2014ActualPhase 4NCT02106962Use of Topical Tranexamic Acid and Bacitracin in Dialysis PatientsCalifornia Institute of Renal Research · Arteriovenous FistulaCompletedHROWCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 14 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner